BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15692075)

  • 1. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
    Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive factors and breast cancer risk among older women.
    Shantakumar S; Terry MB; Teitelbaum SL; Britton JA; Millikan RC; Moorman PG; Neugut AI; Gammon MD
    Breast Cancer Res Treat; 2007 May; 102(3):365-74. PubMed ID: 17033925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breastfeeding experience and breast cancer risk among postmenopausal women.
    Enger SM; Ross RK; Paganini-Hill A; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):365-9. PubMed ID: 9610784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime physical activity and breast cancer risk in pre- and postmenopausal women.
    Dorn J; Vena J; Brasure J; Freudenheim J; Graham S
    Med Sci Sports Exerc; 2003 Feb; 35(2):278-85. PubMed ID: 12569217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of dietary vitamin A, carotenoids, and other antioxidants with the risk of ovarian cancer.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Hankin JH; Nomura AM; Kolonel LN; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):669-76. PubMed ID: 15767348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
    Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
    Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
    Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
    Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.
    Nichols HB; Trentham-Dietz A; Hampton JM; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1212-8. PubMed ID: 15894674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women.
    Duell EJ; Holly EA
    Am J Epidemiol; 2005 Apr; 161(8):741-7. PubMed ID: 15800266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term oral contraceptive use and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Am J Epidemiol; 2005 Jul; 162(1):66-72. PubMed ID: 15961588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breastfeeding reduces breast cancer risk: a case-control study in Tunisia.
    Awatef M; Olfa G; Imed H; Kacem M; Imen C; Rim C; Mohamed B; Slim BA
    Cancer Causes Control; 2010 Mar; 21(3):393-7. PubMed ID: 19921444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
    Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.